Does ENZALUTAMIDE Cause Speech disorder? 113 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Speech disorder have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
113
Reports of Speech disorder with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
19
Deaths
40
Hospitalizations
How Dangerous Is Speech disorder From ENZALUTAMIDE?
Of the 113 reports, 19 (16.8%) resulted in death, 40 (35.4%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Speech disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Speech disorder?
CARBIDOPA\LEVODOPA (1,291)
PREGABALIN (827)
QUETIAPINE (762)
ADALIMUMAB (684)
FINGOLIMOD (583)
DIMETHYL (576)
OLANZAPINE (547)
PIMAVANSERIN (540)
NATALIZUMAB (528)
GABAPENTIN (515)
Which ENZALUTAMIDE Alternatives Have Lower Speech disorder Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE